Advertisement
Screener

TYBOURNE CAPITAL MANAGEMENT (HK) LTD Current Holdings: USA Stocks

TYBOURNE CAPITAL MANAGEMENT (HK) LTD current holdings: USA Stocks

TYBOURNE CAPITAL MANAGEMENT (HK) LTD reported $0.03 billion in share positions in stocks (listed in the US), 4 positions, in its Form 13F for the quarter ended 2025-09-30; the largest are TSHA, FBRX, ALMS.

  • TSHA: Country of operation United States; Class COM SHS; Shares 3,700,000; Value $12,099,000.
  • FBRX: Country of operation United States; Class COM NEW; Shares 786,647; Value $11,799,705.
  • ALMS: Country of operation United States; Class COM; Shares 1,399,250; Value $5,583,008.
  • ZNTL: Country of operation United States; Class COM; Shares 961,486; Value $1,451,844.

Form 13F-HR as filed (SEC CIK 1553936): quarter ended 2025-09-30, filed 2025-11-06. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Performance is each holding's price change from its close on the 2025-09-30 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.

StockCountry of operationClassSharesValue% of listedQuarter endFiledPerformance
TSHA
TAYSHA GENE THERAPIES INC (TSHA US)
United StatesCOM SHS3,700,000$12,099,00039.11%2025-09-302025-11-06+52.60%
FBRX
FORTE BIOSCIENCES INC (FBRX US)
United StatesCOM NEW786,647$11,799,70538.15%2025-09-302025-11-06
ALMS
ALUMIS INC (ALMS US)
United StatesCOM1,399,250$5,583,00818.05%2025-09-302025-11-06— split 2026-01-06, ratio not on file
ZNTL
ZENTALIS PHARMACEUTICALS INC (ZNTL US)
United StatesCOM961,486$1,451,8444.69%2025-09-302025-11-06+79.80%

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet